arrow
A

Anne Therese Tveter

Center for Treatment of Rheumatic and Musculoskeletal Diseases
H指数:22
被引数:1,815

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Occupational therapist-led versus rheumatologist-led care in people with hand osteoarthritis in Norway: an open-label, multicentre, randomised controlled, non-inferiority trial

挪威手骨关节炎患者中作业治疗师主导与风湿病学家主导的护理比较:一项开放标签、多中心、随机对照、非劣效性试验

2025-06-100
PRE
Predicting prolonged work absence due to musculoskeletal disorders: development, validation, and clinical usefulness of prognostic prediction models

预测因肌肉骨骼疾病导致的工作长期缺勤:预后预测模型的发展、验证及临床实用性

2025-04-080
OA
Humoral and cellular responses to a fifth bivalent SARS-CoV-2 vaccine dose in patients with immune-mediated inflammatory diseases on tumour necrosis factor inhibitors: a prospective cohort study
2025-01-010
PRE
T cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients on TNF inhibitor treatment: a prospective cohort study
2024-10-011
OAAI
Patients with axial spondyloarthritis reported willingness to use remote care and showed high adherence to electronic patient-reported outcome measures: an 18-month observational study

中轴型脊柱关节炎患者报告愿意使用远程护理,并对电子患者报告的结果指标表现出很高的依从性: 一项为期18个月的观察性研究

2024-08-210
OAAI
NON-INFERIOR OUTCOMES IN OCCUPATIONAL-LED COMPARED TO RHEUMATOLOGIST-LED CARE FOR HAND OSTEOARTHRITIS: EVIDENCE FROM A NON- INFERIORITY RANDOMIZED CONTROLLED TRIAL

与风湿病学家主导的护理相比,职业主导的手骨关节炎非劣效结局:来自一项非劣效性随机对照试验的证据

2024-06-010
PRE
Dynamics of SARS-CoV-2 immunity after vaccination and breakthrough infection in rituximab-treated rheumatoid arthritis patients: a prospective cohort study
2024-02-222
OAAI
Evaluating Osteoarthritis Management Programs: outcome domain recommendations from the OARSI Joint Effort Initiative
2023-07-016
OAAI
Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort study
2023-01-0121
OAAI
Effectiveness of adding motivational interviewing or a stratified vocational advice intervention to usual case management on return to work for people with musculoskeletal disorders: the MI-NAV randomised controlled trial
2022-11-257
OAAI
The persistence of anti-Spike antibodies following two SARS-CoV-2 vaccine doses in patients on immunosuppressive therapy compared to healthy controls-a prospective cohort study
2022-10-0513
OAAI
Immunogenicity and Safety of Standard and Third-Dose SARS-CoV-2 Vaccination in Patients Receiving Immunosuppressive Therapy
2022-06-2945
OA